Literature DB >> 27306215

Laminin-adherent versus suspension-non-adherent cell culture conditions for the isolation of cancer stem cells in the DAOY medulloblastoma cell line.

Javier de la Rosa1, Ander Sáenz Antoñanzas1, Mehdi H Shahi2, Bárbara Meléndez3, Juan A Rey4, Javier S Castresana5.   

Abstract

Medulloblastoma (MB) is a highly malignant tumor of childhood. MB seems to be initiated and maintained by a small group of cells, known as cancer stem cells (CSCs). The CSC hypothesis suggests that a subset of tumor cells is able to proliferate, sustain the tumor, and develop chemoresistance, all of which make of CSC an interesting target for new anticancer therapies. The MB cell line DAOY was cultured in suspension by a medullosphere traditional culturing method and in adherent conditions by laminin-pre-coated flasks and serum-free medium enriched with specific growth factors. An increase in the stem features was shown when cells were successively cultured in hypoxia conditions. By contrast, a reduction in these properties was appreciated when cells were exposed to differentiation conditions. In addition, the CD133+ and CD133- subpopulations were isolated from cells grown in laminin-pre-coated flasks, and in vitro experiments showed that the CD133+ fraction represented the stem population and it could have CSC with a higher probability than the CD133- fraction. We can conclude that the laminin culture method in adherent conditions and the medullosphere traditional culturing method in suspension are similarly good for obtaining stem-like cells in the DAOY cell line.

Entities:  

Keywords:  CD133; Cancer stem cells; Hypoxia; Laminin; Medulloblastoma; Medullospheres; Neurospheres

Mesh:

Substances:

Year:  2016        PMID: 27306215     DOI: 10.1007/s13277-016-5119-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  22 in total

1.  Targeting the enhancer of zeste homologue 2 in medulloblastoma.

Authors:  Irina Alimova; Sujatha Venkataraman; Peter Harris; Victor E Marquez; Paul A Northcott; Adrian Dubuc; Michael D Taylor; Nicholas K Foreman; Rajeev Vibhakar
Journal:  Int J Cancer       Date:  2012-07-30       Impact factor: 7.396

Review 2.  Brain tumour stem cells.

Authors:  Angelo L Vescovi; Rossella Galli; Brent A Reynolds
Journal:  Nat Rev Cancer       Date:  2006-06       Impact factor: 60.716

3.  Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia.

Authors:  Ed R Blazek; Jennifer L Foutch; Guitta Maki
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-02       Impact factor: 7.038

4.  Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis.

Authors:  Yunfei Zhou; Yan Zhou; Takashi Shingu; Li Feng; Zhao Chen; Marcia Ogasawara; Michael J Keating; Seiji Kondo; Peng Huang
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

5.  Glioma stem cells: better flat than round.

Authors:  Kevin Woolard; Howard A Fine
Journal:  Cell Stem Cell       Date:  2009-06-05       Impact factor: 24.633

Review 6.  CD133: molecule of the moment.

Authors:  D Mizrak; M Brittan; M R Alison
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

Review 7.  Cancer stem cells and the biology of brain tumors.

Authors:  Debora Gazzana Flores; Pitia Flores Ledur; Ana Lucia Abujamra; Algemir Lunardi Brunetto; Gilberto Schwartsmann; Guido Lenz; Rafael Roesler
Journal:  Curr Stem Cell Res Ther       Date:  2009-12       Impact factor: 3.828

8.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

9.  MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.

Authors:  Pasqualino de Antonellis; Chiara Medaglia; Emilio Cusanelli; Immacolata Andolfo; Lucia Liguori; Gennaro De Vita; Marianeve Carotenuto; Annamaria Bello; Fabio Formiggini; Aldo Galeone; Giuseppe De Rosa; Antonella Virgilio; Immacolata Scognamiglio; Manuela Sciro; Giuseppe Basso; Johannes H Schulte; Giuseppe Cinalli; Achille Iolascon; Massimo Zollo
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

Review 10.  The impact of O2 availability on human cancer.

Authors:  Jessica A Bertout; Shetal A Patel; M Celeste Simon
Journal:  Nat Rev Cancer       Date:  2008-11-06       Impact factor: 60.716

View more
  3 in total

1.  Erbb4 Is Required for Cerebellar Developmentand Malignant Phenotype of Medulloblastoma.

Authors:  Juncal Aldaregia; Peio Errarte; Ane Olazagoitia-Garmendia; Marian Gimeno; Jose Javier Uriz; Timothy R Gershon; Idoia Garcia; Ander Matheu
Journal:  Cancers (Basel)       Date:  2020-04-17       Impact factor: 6.639

2.  Bioprocessing strategies to enhance the challenging isolation of neuro-regenerative cells from olfactory mucosa.

Authors:  Melanie Georgiou; Joana Neves Dos Reis; Rachael Wood; Patricia Perez Esteban; Victoria Roberton; Chris Mason; Daqing Li; Ying Li; David Choi; Ivan Wall
Journal:  Sci Rep       Date:  2018-09-27       Impact factor: 4.379

3.  In Vitro Monolayer Culture of Dispersed Neural Stem Cells on the E-Cadherin-Based Substrate with Long-Term Stemness Maintenance.

Authors:  Shuhui Yang; Zheng Cao; Jinjin Zhu; Zhe Zhang; He Zhao; Lingyun Zhao; Xiaodan Sun; Xiumei Wang
Journal:  ACS Omega       Date:  2019-10-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.